Ascorbic Acid and the Premature Infant

Area of Science:

• Neonatology
• Nutritional Science
• Biochemistry

Background:

• Limited data exists on plasma ascorbic acid (AscA) needs in premature infants (<37 weeks gestation).
• Ascorbic acid plays a crucial role in infant health and development.
• Understanding factors influencing AscA levels is vital for optimizing care in this vulnerable population.

Purpose of the Study:

• To investigate the relationship between infant characteristics, maternal health, and infant plasma AscA levels (pAscA) during postnatal development.
• To determine the influence of early postnatal AscA levels (EpAscA) on later infant morbidities.
• To identify key factors affecting pAscA in premature infants.

Main Methods:

• Prospective longitudinal observational study involving infants ≤34 weeks gestation.
• Analysis of over 200 urine and plasma data points, including demographics and hospital course.
• Statistical analysis to identify associations between maternal/infant factors and pAscA.

Main Results:

• Maternal smoking, magnesium sulfate (MgSO4) exposure, and increasing gestational/postnatal age were linked to lower pAscA.
• Non-white infants and those born ≤30 weeks who developed bronchopulmonary dysplasia or retinopathy of prematurity had lower pAscA.
• Prenatal smoking, MgSO4, birth gestational age, and race were identified as negative influences on pAscA.

Conclusions:

• Prenatal and postnatal factors significantly influence initial pAscA and metabolism in premature infants.
• These factors may impact organ health and disease risk, highlighting the need for tailored nutritional assessments.
• Adjusting dietary targets for ascorbic acid may be necessary for this high-risk population.